Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Farshid Dayyani

Showing results (1-10 of 115) with videos related to

Pageof 12
Sort By:
BMC Cancer|March 4, 2023
Phase II clinical trial of sequential treatment with systemic chemotherapy and intraperitoneal paclitaxel for gastric and gastroesophageal junction peritoneal carcinomatosis - STOPGAP trialMaheswari Senthil, Farshid Dayyani
Journal of Oncology Practice|August 13, 2019
Management of Urothelial Bladder Cancer in Clinical Practice: Real-World Answers to Difficult QuestionsNataliya Mar, Farshid Dayyani
Diseases (Basel, Switzerland)|June 1, 2022
Early Adoption of Checkpoint Inhibitors in Patients with Metastatic Gastric Adenocarcinoma-A Case Series of Non-Operative Long-Term SurvivorsDalia Kaakour, Garrett Ward, Farshid Dayyani
Seminars in Interventional Radiology|December 17, 2020
Therapy in Advanced Hepatocellular CarcinomaHanna Javan, Farshid Dayyani, Nadine Abi-Jaoudeh
Journal of Neuroimmunology|December 31, 2003
Impact of type-I-interferon on monocyte subsets and their differentiation to dendritic cells. An in vivo and ex vivo study in multiple sclerosis patients treated with interferon-betaF Then Bergh, Farshid Dayyani, Loems Ziegler-Heitbrock
International Journal of Cancer|March 3, 2011
Steps in prostate cancer progression that lead to bone metastasisJung-Kang Jin, Farshid Dayyani, Gary E Gallick
Annals of Translational Medicine|March 14, 2022
Screening and verification of potential gene targets in esophageal carcinoma by bioinformatics analysis and immunohistochemistryPingwu Wen, Farshid Dayyani, Randa Tao, et al.
Biomed Research International|January 3, 2017
Clinically Meaningful Use of Blood Tumor Markers in OncologyStefan Holdenrieder, Lance Pagliaro, David Morgenstern, et al.
Diseases (Basel, Switzerland)|April 24, 2023
Durable Response after Repeat Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in a Patient with Extensive Mucinous Adenocarcinoma of the AppendixDalia Kaakour, Garrett Ward, Maheswari Senthil, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 18, 2025
Ethnic Demographic Shifts and the Rise of Early-Onset Esophageal, Gastric and Colorectal Malignancies in the United StatesElaine Chiao, Tevan Luong, Aditya Mahadevan, et al.
Pageof 12

Showing results (1-10 of 115) with videos related to

Sort By:
Pageof 12
BMC Cancer|March 4, 2023
Phase II clinical trial of sequential treatment with systemic chemotherapy and intraperitoneal paclitaxel for gastric and gastroesophageal junction peritoneal carcinomatosis - STOPGAP trialMaheswari Senthil, Farshid Dayyani
Journal of Oncology Practice|August 13, 2019
Management of Urothelial Bladder Cancer in Clinical Practice: Real-World Answers to Difficult QuestionsNataliya Mar, Farshid Dayyani
Diseases (Basel, Switzerland)|June 1, 2022
Early Adoption of Checkpoint Inhibitors in Patients with Metastatic Gastric Adenocarcinoma-A Case Series of Non-Operative Long-Term SurvivorsDalia Kaakour, Garrett Ward, Farshid Dayyani
Seminars in Interventional Radiology|December 17, 2020
Therapy in Advanced Hepatocellular CarcinomaHanna Javan, Farshid Dayyani, Nadine Abi-Jaoudeh
Journal of Neuroimmunology|December 31, 2003
Impact of type-I-interferon on monocyte subsets and their differentiation to dendritic cells. An in vivo and ex vivo study in multiple sclerosis patients treated with interferon-betaF Then Bergh, Farshid Dayyani, Loems Ziegler-Heitbrock
International Journal of Cancer|March 3, 2011
Steps in prostate cancer progression that lead to bone metastasisJung-Kang Jin, Farshid Dayyani, Gary E Gallick
Annals of Translational Medicine|March 14, 2022
Screening and verification of potential gene targets in esophageal carcinoma by bioinformatics analysis and immunohistochemistryPingwu Wen, Farshid Dayyani, Randa Tao, et al.
Biomed Research International|January 3, 2017
Clinically Meaningful Use of Blood Tumor Markers in OncologyStefan Holdenrieder, Lance Pagliaro, David Morgenstern, et al.
Diseases (Basel, Switzerland)|April 24, 2023
Durable Response after Repeat Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in a Patient with Extensive Mucinous Adenocarcinoma of the AppendixDalia Kaakour, Garrett Ward, Maheswari Senthil, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 18, 2025
Ethnic Demographic Shifts and the Rise of Early-Onset Esophageal, Gastric and Colorectal Malignancies in the United StatesElaine Chiao, Tevan Luong, Aditya Mahadevan, et al.
Pageof 12